CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Impact of adoption of CECL	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Earnings (Deficit)	Accumulated Earnings (Deficit) Impact of adoption of CECL
Beginning balance (in shares) at Dec. 31, 2019			28,865,610,000
Beginning balance at Dec. 31, 2019	$ 426,339	$ (5,051)	$ 283	$ 423,619	$ 0	$ 2,437	$ (5,051)
Increase (Decrease) in Stockholders' Equity
Sale of common stock (in shares)			4,600,000,000
Sale of common stock	73,232		$ 46	73,186
Offering costs	(341)			(341)
Stock-based compensation (in shares)			(23,278,000)
Stock‑based compensation	1,339			1,339
Net income	21,840					21,840
Dividends declared	(44,343)					(44,343)
Ending balance (in shares) at Dec. 31, 2020			33,442,332,000
Ending balance at Dec. 31, 2020	473,015		$ 329	497,803	0	(25,117)
Increase (Decrease) in Stockholders' Equity
Sale of common stock (in shares)			13,637,237,000
Sale of common stock	204,779		$ 136	204,643
Offering costs	(436)			(436)
Stock-based compensation (in shares)			64,489,000
Stock‑based compensation	1,940			1,940
Other comprehensive income	2,844				2,844
Net income	60,460					60,460
Dividends declared	$ (63,974)					(63,974)
Ending balance (in shares) at Dec. 31, 2021	47,144,058		47,144,058,000
Ending balance at Dec. 31, 2021	$ 678,628		$ 465	703,950	2,844	(28,631)
Increase (Decrease) in Stockholders' Equity
Sale of common stock (in shares)			7,190,369,000
Sale of common stock	106,267		$ 72	106,195
Offering costs	(233)			(233)
Stock-based compensation (in shares)			109,556,000
Stock‑based compensation	2,876			2,876
Other comprehensive income	4,697				4,697
Net income	29,785					29,785
Dividends declared	$ (74,480)					(74,480)
Ending balance (in shares) at Dec. 31, 2022	54,443,983		54,443,983,000
Ending balance at Dec. 31, 2022	$ 747,540		$ 537	$ 812,788	$ 7,541	$ (73,326)